For the first time, raw data on Norwegian coronavirus genes will be freely available through the open gene bank ENA.
Bacteria and viruses
Several commonly prescribed medications used for completely different illnesses can enhance or reduce the activity of the influenza virus.
Lybe Scientific, a start-up company based on NTNU research, is entering the market as a provider of high-quality diagnostic solutions – not just for COVID-19 diagnostics, but also other areas such as the common flu and sexually transmitted diseases.
NTNU researchers have started testing a COVID-19 test strategy developed in house: saliva samples you take yourself, without involving health personnel. This means that researchers may be able to knock back the coronavirus epidemic faster, more easily and much more cheaply than today. The method is now being tested on NTNU students.
NTNU researchers are on track to find drug combinations that could help stop the coronavirus across the globe.
The story of what happened when a molecular biologist, some engineers and PhDs and postdocs from NTNU and St Olavs Hospital put their heads together to design a completely different kind of coronavirus test.
It’s understandable that the Danes want to be on the safe side and exterminate the mink to stop this variant of the coronavirus, says Andreas Christensen, an associate professor at NTNU.
The Norwegian University of Science and Technology (NTNU) has signed agreements to deliver as many as one million COVID-19 test kits to DTU, the Technical University of Denmark, and APS LABS, an Indian biotech company. “It is very positive that this technology can now also be useful internationally,” says Bent Høie, Norway’s Minister of Health and Care Services.
Researchers at NTNU have managed to show exactly how the tuberculosis bacterium kills its host cell by filming the process in detail for the first time. Every year, 1.5 million people die of TB. Watch the clips below.
Cancer researcher Marit Otterlei made a chance discovery of a brand new antibiotic that has proven effective after several experiments.
One combination of two drugs was so effective that researchers hope others can begin clinical trials on the drugs now.
COVID-19 has created an extra workload for people in socially critical professions. How does this added strain affect them and how do they handle it?
Testing families of four or more people would be an effective way to reduce the spread of the coronavirus infection, according to a data simulation model developed at NTNU. The model has initially been used to determine the best testing strategy for Oslo.
NTNU researchers recently figured out a whole new method for testing people for the coronavirus. The university is now producing tests on a continuous basis, under the auspices of the Norwegian Directorate of Health. Currently 100 000 tests a day are being manufactured, with production soon likely to be scaled up dramatically.
Norway’s Ministry of Health and Care Services confirmed Friday that it will roll out coronavirus test kits developed by researchers from NTNU and St Olavs Hospital by the last week of April/early May. The kits will more than triple Norway’s testing capacity during the rollout.
Italy’s budget deficit is skyrocketing. Yet people there are not debating the cost of a human life, or whether the shutdown of the country is worth it.
Two weeks ago, doctors at St. Olavs Hospital in Trondheim were running out of reagents needed to do COVID-19 tests. They asked colleagues at NTNU to develop a backup solution. Now, Norway is gearing up to use the new approach to test 150,000 people a week after Easter.
Medical researchers worldwide are racing to find treatments and vaccines to combat the coronavirus pandemic sweeping the globe. A new website offers up-to-date summaries on available and emerging options against COVID-19.
Restlessness, insomnia, ruminating and aching muscles. Here are one professor’s tips for anyone who is struggling with anxiety and fear due to the coronavirus.
There’s no effective treatment for the coronavirus that causes COVID-19, which was first detected in Wuhan, China. Developing new drugs and vaccines can take years. Existing drugs offer a possible quick response to the potential pandemic.
Nearly 40 million people were living with HIV in 2017, the UN says, with just over half taking antiretroviral therapy. These drugs have cut AIDS-related deaths by more than half since the 2004 peak, but the disease cannot be cured. A new mechanism uncovered by a Norwegian research group could improve the chances of developing one.